# Exendin-4 as a Treatment for Parkinson's Disease - Pilot Study

> **NCT01174810** · PHASE2 · UNKNOWN · sponsor: **University College, London** · enrollment: 40 (estimated)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Exenatide

## Key facts

- **NCT ID:** NCT01174810
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-07
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2012-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01174810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01174810, "Exendin-4 as a Treatment for Parkinson's Disease - Pilot Study". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01174810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*